openPR Logo
Press release

BCG Vaccine Market Share, Size, Forecast and Trends by 2023

01-03-2019 06:51 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Market Data Forecast

BCG Vaccine Market Share, Size, Forecast and Trends by 2023

BCG Vaccine Market Overview

BCG vaccine stands for Bacillus Calmette-Gurin (BCG) vaccine. It prevents TB and is the only vaccine in the market which could do that. A single dose is given to an infant soon after birth in countries with high occurrence of TB. In countries which TB is not a common occurrence only high risk infants are treated with it. Adults are only treated with this vaccine if their exposure to drug-resistant TB is a regular occurrence.

Request for Sample @

Increasing number of cases of TB all over the world particularly in the developing countries of APAC, rapid advancements in technology in the field of medical research on vaccines, and savory government policies and initiatives with improved funding are driving the growth of this market

BCG Vaccine Market Forecast Report (2018-2023)

Global BCG Vaccine Market size was around USD X.XX million in 2018. It is expected to grow at a CAGR of X.XX% to reach USD X.XX million by 2023.

Browse Report Brief and TOC @

BCG Vaccine Market Segmentation

The market segmentation is very broad and is only classified by demographics into Paediatrics (0-18 years), and Adults (19-35 years). Paediatrics is a clear market leader accounting for more than three quarters of market share and is likely to gain even more in the forecast period. It is because BCG vaccination has become mandatory in most of the countries as part of the national immunization program. Moreover, the efficacy of the vaccine is reduced if it is not administered in infancy. The usage of this vaccine is highest in Kenya. Polio and hepatitis B vaccines are usually administered alongside it.

Classification by geography entails North America, Latin America, Europe, Asia Pacific and Middle East and Africa. North America accounted for the largest market share while Asia Pacific is expected to grow with the highest CAGR due to TB eradication campaigns going on in the developing countries.

Major Players:

The major companies dominating this market for its products and services are

Merck & Co., Inc.,
Sanofi Pasteur,
Japan BCG Laboratory.
China National Biotec Group
Serum Institute of India Pvt. Ltd.,
InterVax Ltd.,
Green Signal Bio Pharma Limited (GSBPL),
tatens Serum Institute.
Buy now @

Customize Report @

About Us

Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.

For more information:

Abhishek Shukla

Sales Manager at Market Data Forecast


Tel: +1-888-702-9626


This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release BCG Vaccine Market Share, Size, Forecast and Trends by 2023 here

News-ID: 1467174 • Views: 374

More Releases from Market Data Forecast

Veterinary Vaccines market value is estimated to grow at a CAGR of 5.5% to incre …
Overview: Veterinary Vaccines Market has seen significant growth over the past few years, due to alarm of imminent epidemics that have led to substantial losses, particularly in poultry segment. View sample and decide: Market views: Global Veterinary Vaccines market value is estimated to grow at a CAGR of 5.5% to increase to reach a market value to USD 8.46 Billion by 2023. Drivers and restraints: Veterinary Vaccine market has displayed a noteworthy growth in recent years which
Protein Labelling Market Global Growth, Trends, And Forecast To 2024
Recent developments: Proteins are the biggest and most essential biomolecules in a living life form, as they are imperative to the working of a creature. When they are shaped inside a cell, proteins associate with different biomolecules and do jobs to keep the cell alive. Merck's FITC labeling kit gives intends to rapidly and just mark antibodies or different proteins with fluorescein. Coordinate marking of the essential immune response disposes of the
Agricultural biotechnology market– Dupont opened its integrated science and bi …
Recent Developments Du Pont is a science and technology company. This company introduce agriculture products, containing the soybean seed and hybrid corn varients mainly under the brand named Pioneer, canola, sorghum, sunflower,  wheat, and rice seeds; silage inoculants, and insect,  weed, disease control products, DuPont introduced its first integrated science and biotechnology center, the DuPont Knowledge Center (DKC) in Hyderabad, Telangana state, in 2008. It is a 20-acre campus with a recent
The endovenous ablation segment is expected to command the major share of the Eu …
Overview The Europe Varicose Vein Treatment Market was worth USD 95.4 million in 2018 and estimated to be growing at a CAGR of 6.3%, to reach USD 129.49 million by 2023. The varicose vein treatment market is mainly driven by the rising cases of varicose veins. This condition of enlarged veins appears mostly in feet and legs. It can be caused by pregnancy, hormonal changes, genetic disorders and high blood pressure. View a

All 5 Releases

More Releases for BCG

BCG Vaccine Booming Segments; Investors Seeking Growth | Sanofi Pasteur, Japan B …
Latest Research Study on Global BCG VaccineMarket published by AMA, offers a detailed overview of the factors influencing the global business scope.Global BCG Vaccine Market research report shows the latest market insights with upcoming trends and breakdown of the products and services.The report provides key statistics on the market status, size, share, growth factors, Challenges and Current Scenario Analysis of the Global BCG Vaccine.This Report also covers the emerging player's
Emerging Trends in BCG Vaccine Market by 2023
BCG vaccine market was valued at from $20,366 thousand in 2016, and is estimated to reach $28,051 thousand by 2023, growing at a CAGR of 4.6% from 2017 to 2023. The Indian BCG vaccines market holds the highest share in the global BCG vaccines market. Get PDF sample copy @ As there is no current alternative to BCG vaccine, therefore there is an urgent need to improve the methods used for
BCG Vaccine Market 2018 Type and Application, Forecast to 2023
This report studies the BCG Vaccine market. BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it
Global BCG Vaccine Market 2018- Merck Sanofi Pasteur, Japan BCG Lab, China Natio …
The Global BCG Vaccine Industry 2018 Market Research Report is a professional and in-depth study on the current state of the BCG Vaccine industry. Firstly, BCG Vaccine Market report provides a basic overview of the BCG Vaccine industry including definitions, classifications, applications and BCG Vaccine industry chain structure. Global BCG Vaccine Market analysis is provided for the international market including development history, BCG Vaccine industry competitive landscape analysis, and major regions
BCG Vaccine Market Size, Analysis, and Forecast Report 2017-2022 has announced the addition of the “Global BCG Vaccine Market 2017 Forecast to 2022” The report focuses on global major leading industry players with information such as company profiles, product picture and specification. BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine
BCG Vaccine Market Growth 2017-2022 Japan BCG Lab, Intervax, GSBPL
BCG Vaccine Market Research 2017 A market study ” Global BCG Vaccine Market ” will help you understand, formulate and implement strategic decisions by offering critical data, insights and analysis from technology as well as commercial perspective on the BCG Vaccine market. It encloses an in-depth Research of the BCG Vaccine market state and the competitive landscape globally. This report consist of comprehensive market data, on a granular level, providing a